No comments on todays action? Anyone notice the blatant attempts - occasionally successful - at driving the price down using 100 share sacrificial offerings? Any thoughts on the effect of options expiration versus the general market?
It's slowly dawning on my that Gliatech has something I like a great deal: focus. At first glance, it appears that the ADCON products are totally distinct from the rest of the company's efforts. But it's worth noting that they all share a common origin. All came about as a result of a detailed study of how glial cells behave.
Yes, this is an oxymoron of sorts since the company is after all called Gliatech. But it's easy to miss this and think that they branched out into something completely different while they really didn't.
Call it unpaid hype if you like - Rick, I'm sure you already know so you're welcome to call it a trivial observation - but I really do feel it's an important one.
Incidentally, I feel that NABI is in a similar situation. They collect a lot of human plasma; generally from people with antibodies to diseases of interest. That's how you get the gamma globulin. But as a result of a business focused on that, they get to take a look at all sorts of interesting things present in the ``samples" they get. This is a valuable research tool in and of itself.
No, I didn't like todays action either. But if you look at the chart, it doesn't look particularly bad. More like normal brownian motion within the trend. And this in a down market and on an options expiration day. Not bad at all.
In the words of the immortal Cato, et sequitur, I believe all GLIA shorts should be terminated with extreme prejudice.
And to satisfy truth in advertising, this is unpaid promotion and I'm kind of long when it comes to GLIA shares! Moreover, I can use all the help I can get; my grass shack needs a lot of maintenance.....
Thanks, Torben |
